Tavilermide是一种选择性的TrkA部分激动剂。
CAS：263251-78-1
分子式：C24H32N6O11
分子量：580.54
纯度：98%
存储：Store at -20°C

Background:

Tavilermide is a selective, partial agonist of TrkA, or a nerve growth factor (NGF) mimetic.

Tavilermide (MIM-D3) is a tyrosine kinase TrkA receptor agonist, which can be used to treat dry eye.Tavilermide is a proteolytically stable, cyclic peptidomimetic that has been shown to be a partial TrkA receptor agonist. Tavilermide demonstrates activities similar to NGF (but does not bind to the p75NTR receptor) and can potentiate the effects of suboptimal concentrations of NGF[1].

[1]. Meerovitch K, et al. Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye. Clin Ophthalmol. 2013;7:1275-85.